PharmaBoardroom

Top Five Global CROs

Driven by increased demand from Big Pharma, mid-caps, and biotechs for outsourcing services, the USD 70 billion global contract research organisation…

Global COVID-19 Vaccine Distribution Snapshot 2022

UNICEF is forecasting that between 16.8 billion and 20.9 billion COVID-19 vaccine doses will be produced in 2022. The Economist Intelligence Unit…

Pharma Industry Taking Lead to Safely Manufacture Antibiotics

Antimicrobial pollution is a major global health and environmental risk. Shawview Consulting’s Brendan Shaw and Nicolai Schaaf of SIWI uncover what…

Global Pharma Sales & Price Projections 2022

Pharmaceutical sales are expected to rise by 4.9 percent in 2022 according to the Economist Intelligence Unit (EIU) with the US continuing to lead the…

Novartis Announces Major Restructuring to “Power Next Phase”

Exactly five months after concluding that it was the right time to “monetize” its investment in a cross-town rival – providing Roche “full…

Five Trends to Watch in Global Healthcare and Life Sciences in…

In 2022 global healthcare will continue to feel the effects of the pandemic and although COVID-19 has become less virulent, with the global death rate…

Pierluigi Antonelli – CEO, Angelini Pharma

Speaking exclusively to PharmaBoardroom, Pierluigi Antonelli outlines Angelini Pharma's progress in transforming from a traditional, Italy-focused,…

Gianfranco Nazzi – CEO, Almirall

Almirall CEO Gianfranco Nazzi dives into the new strategic focus of the global biopharmaceutical company with HQ in Barcelona as it seeks to serve the…